洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-IOR-17013259】Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults

基本信息
登记号

ChiCTR-IOR-17013259

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2017-11-03

临床申请受理号

/

靶点

/

适应症

Overweight/Obesity

试验通俗题目

Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults

试验专业题目

Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults

试验分类
试验类型

随机交叉对照

试验分期

其它

随机化

Randomized

盲法

Single-blind for Trial subjects

试验项目经费来源

No

试验范围

/

目标入组人数

25

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

1. Chinese men aged between 18 and 34 years; 2. With overweight/obesity (Body Mass Index is higher than 22.9 km/m^2); 3. Physically inactive (moderate-intensity physical activity is less than 150 minutes per week for the past 3 months); 4. Total time spent sitting is more than 5 hours per day; 5. Fluent in English.;

排除标准

1. Allergic to milk or gluten; 2. With history of cardiovascular disease and/or diabetes; 3. Fasting blood glucose is over than 7 mmol/L, and/or 2-hour postprandial glucose in the 75-g Oral glucose tolerance test is over than 199 mg/dL, and/or HbA1C is over than 6.4%; 4. Smoker; 5. With conditions that alter limit capability to walk on a treadmill; 6. Taking any medications known to affect lipid or glucose metabolism; 7. Not fluent in English.;

研究者信息
研究负责人姓名
试验机构

香港中文大學教育學院

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

Department of Sports Science and Physical Education, Faculty of Education, The Chinese University of Hong Kong的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品